Lung Disease News and Research

RSS

Wits University begins South African trial of Novavax COVID-19 vaccine

NVX-CoV2373 is produced by the biotech company, Novavax (Maryland, U.S.A). Novavax is a late-stage biotechnology company that develops next-generation vaccines for serious infectious diseases.

17 Aug 2020

With COVID vaccine trial, rural Oregon clinic steps onto world stage

From the outside, it appears to be just another suburban allergy clinic, a tidy, tan brick-and-cinder-block building set back from a busy highway and across the road from an auto parts store.

17 Aug 2020

Care home residents with Covid-19 are either asymptomatic or have 'atypical' symptoms

Many care home residents who have Covid-19 infection are either asymptomatic or experience ‘atypical’ symptoms – according to a new study from the University of East Anglia (UEA) and North Norfolk Primary Care, supported by UEA Health and Social Care Partners.

13 Aug 2020

Research looks at convalescent plasma use in COVID-19 mouse model

A new study by researchers at the University of Iowa and published on the preprint server bioRxiv in August 2020 reports the utility of a mouse model that recapitulates several aspects of human COVID-19 and can reflect the antiviral efficacy of new drugs as well.

12 Aug 2020

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Now, a new study published in the Journal of Adolescent Health shows that teens and young adults may have a heightened risk of COVID-19 if they vape or smoke cigarettes. Cigarette smokers are seven times more likely to be infected with SARS-CoV-2. Meanwhile, people who vape are five times more likely to be diagnosed with the viral infection.

11 Aug 2020

One-third of children hospitalized with COVID-19 admitted to ICU, study finds

Now, new research has found that children are still at a high risk of developing severe COVID-19. The study shows that one-third of children hospitalized due to COVID-19 were admitted to intensive care units (ICU), a rate similar to adults.

11 Aug 2020

Researchers develop fitness app to reduce hospital visits

An app that can measure fitness at home by hospital out-patients is being shared for free by its Malmö University developer. Such technology could be vital in reducing the number of appointments high risk groups must attend.

10 Aug 2020

Genetic variant in Japanese population increases risk of interstitial lung disease among RA patients

In many cases, a complex interplay between our genes and the environment governs whether or not we will develop a certain disease. Interestingly though, researchers are discovering that the genetic component of disease predisposition may depend on our ethnic background.

10 Aug 2020

Powerful treatment for IPF stops dangerous scar formation in mouse lungs

A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with idiopathic pulmonary fibrosis (IPF).

6 Aug 2020

New peptide molecule offers hope for emphysema

Emphysema is a progressive, debilitating lung disease in which the lung's breathing sacs, or alveoli, enlarge, get thinner, and eventually are destroyed as the cells die off. It can be fatal, and there is currently no cure.

4 Aug 2020

Researchers initiate multiple studies to identify coronavirus-related heart problems

COVID-19 is shown to impact the heart and, in some cases, have long-lasting cardiac effects. To discover the extent to which COVID-19 affects the heart, cardiologists and researchers with the University of Miami Miller School of Medicine have begun multiple studies.

4 Aug 2020

Insights into prevalence, incidence, and impact of COPD in older adults

"Recognizing and Treating COPD in Older Adults," the latest issue of the What's Hot newsletter from The Gerontological Society of America, addresses what is known about the prevalence, incidence, and impact of chronic obstructive pulmonary disease (COPD) in older adults.

3 Aug 2020

The race to a coronavirus vaccine

As the number of coronavirus disease (COVID-19) cases skyrocket to a staggering 18 million, the race to attain vaccine approval is on. More than a hundred candidate vaccines are being developed and tested to prevent infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, many vaccine candidates are undergoing human stage 2 and 3 trials to prove their efficacy and safety.

2 Aug 2020

UOttawa's Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists

The Faculty of Medicine has awarded 58 clinical research chairs to top clinician-scientists in a five-year, $40 million investment to drive clinical research excellence and enhance health and patient care.

30 Jul 2020

Smoking worsens COVID-19 severity, warn researchers

A study conducted by researchers at the University of California, Los Angeles, suggests that smoking increases the risk of more severe lung disease in cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

30 Jul 2020

Scientists develop human lung organoids to study SARS-CoV-2 infection

Now, a new study published on the preprint server bioRxiv in July 2020 reports the development of a human distal lung culture system that can be functionally tested. This will help not only to understand how this infection produces disease but also to test the proliferative capacity of the stem cells in this part of the body.

30 Jul 2020

Study sheds wider light on the clinical profile of patients with pulmonary hypertension

When most people think of high blood pressure, they think of being tested with an arm cuff at a doctor's appointment. That type of blood pressure is separate from pulmonary hypertension (PH), which is high blood pressure in the lung arteries.

28 Jul 2020

Pitt collaborative receives $7 million to evaluate convalescent plasma therapy for COVID-19

A team of University of Pittsburgh, Michigan Medicine, Medical University of South Carolina and Stanford Medicine. researchers recently were awarded funds from the National Heart, Lung, and Blood Institute in collaboration with the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, totaling more than $7 million to collaboratively study the role of convalescent plasma in mitigating symptoms of COVID-19 in patients with mild illness and preventing the progression of the disease from mild to severe.

28 Jul 2020

Low plasma vitamin D level appears to be an independent risk factor for COVID-19 infection

Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, type 2 diabetes, obesity and cognitive decline, and infections.

27 Jul 2020

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Announcing a new article publication for BIO Integration journal. In this case report the authors Zijun Zhao, Zhanghai He, Hongyan Huang, Jiewen Chen, Shishi He, Ailifeire Yilihamu and Yan Nie from Sun Yat-sen University, Guangzhou, China consider drug-induced interstitial lung disease in breast cancer patients.

27 Jul 2020

Lung Disease News and Research

Wits University begins South African trial of Novavax COVID-19 vaccine

With COVID vaccine trial, rural Oregon clinic steps onto world stage

Care home residents with Covid-19 are either asymptomatic or have 'atypical' symptoms

Research looks at convalescent plasma use in COVID-19 mouse model

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

One-third of children hospitalized with COVID-19 admitted to ICU, study finds

Researchers develop fitness app to reduce hospital visits

Genetic variant in Japanese population increases risk of interstitial lung disease among RA patients

Powerful treatment for IPF stops dangerous scar formation in mouse lungs

New peptide molecule offers hope for emphysema

Researchers initiate multiple studies to identify coronavirus-related heart problems

Insights into prevalence, incidence, and impact of COPD in older adults

The race to a coronavirus vaccine

UOttawa's Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists

Smoking worsens COVID-19 severity, warn researchers

Scientists develop human lung organoids to study SARS-CoV-2 infection

Study sheds wider light on the clinical profile of patients with pulmonary hypertension

Pitt collaborative receives $7 million to evaluate convalescent plasma therapy for COVID-19

Low plasma vitamin D level appears to be an independent risk factor for COVID-19 infection

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

The ultimate guide to lung research tools and protocols eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News